Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer
- 1 February 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (4) , 1068-1072
Abstract
The ubiquitin−proteasome pathway plays a central role in regulation of the production and destruction of cellular proteins. These pathways mediate proliferation and cell survival, particularly in malignant cells. The successful development of the 20S human proteasome inhibitor bortezomib for the treatment of relapsed and refractory multiple myeloma has established this targeted intervention as an effective therapeutic strategy. Herein, the potent, selective, and orally bioavailable threonine-derived 20S human proteasome inhibitor that has been advanced to preclinical development, [(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid 20 (CEP-18770), is disclosed.Keywords
This publication has 23 references indexed in Scilit:
- Functions of the proteasome: from protein degradation and immune surveillance to cancer therapyBiochemical Society Transactions, 2007
- Targeting the proteasome as a therapeutic strategy against haematological malignanciesExpert Opinion on Investigational Drugs, 2006
- A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from BortezomibCancer Cell, 2005
- Intracellular Protein Degradation: From a Vague Idea, through the Lysosome and the Ubiquitin–Proteasome System, and onto Human Diseases and Drug Targeting (Nobel Lecture)Angewandte Chemie International Edition, 2005
- Bortezomib or High-Dose Dexamethasone for Relapsed Multiple MyelomaNew England Journal of Medicine, 2005
- Proteasome Inhibition As a Novel Therapeutic Target in Human CancerJournal of Clinical Oncology, 2005
- Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Novel Microbial Source, a Marine Bacterium of the New Genus SalinosporaAngewandte Chemie International Edition, 2003
- Synthesis of Boronic Acid Analogues of α-Amino Acids by Introducing Side Chains as ElectrophilesThe Journal of Organic Chemistry, 2001
- Structure of 20S proteasome from yeast at 2.4Å resolutionNature, 1997
- Potent α-ketocarbonyl and boronic ester derived inhibitors of proteasomeBioorganic & Medicinal Chemistry Letters, 1996